{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:37:44Z","timestamp":1760647064850,"version":"3.37.3"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221438","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T13:30:16Z","timestamp":1566221416000},"page":"e0221438","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparison of opioids and benzodiazepines dispensing in Australia"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-863X","authenticated-orcid":true,"given":"M. Mofizul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Wollersheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"journal-title":"WHO model list of essential medicines","year":"2017","author":"WHO Expert Committee","key":"pone.0221438.ref001"},{"key":"pone.0221438.ref002","first-page":"38","article-title":"Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain","volume":"160","author":"TK Nuckols","year":"2014","journal-title":"Ann Intern Med"},{"key":"pone.0221438.ref003","unstructured":"Therapeutic Guidelines Limited (2019) eTG complete: psychotropic guidelines. Melbourne. Available from: https:\/\/tgldcdp.tg.org.au\/topicTeaser?guidelinePage = Psychotropic&etgAccess = true."},{"key":"pone.0221438.ref004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/mja16.00066","article-title":"Using opioids in general practice for chronic non-cancer pain: an overview of current evidence","volume":"204","author":"DC Currow","year":"2016","journal-title":"Med J Aust"},{"key":"pone.0221438.ref005","first-page":"304","article-title":"Prescription Opioid and Benzodiazepine Use After Road Traffic Injury","volume":"17","author":"J Berecki-Gisolf","year":"2016","journal-title":"Pain Med"},{"key":"pone.0221438.ref006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12888-016-0909-3","article-title":"Nonmedical use of prescription drugs in the European Union","volume":"16","author":"SP Novak","year":"2016","journal-title":"BMC Psychiatry"},{"key":"pone.0221438.ref007","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/j.pain.0000000000000892","article-title":"Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data","volume":"158","author":"KI Morley","year":"2017","journal-title":"Pain"},{"key":"pone.0221438.ref008","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1176\/appi.ps.201500380","article-title":"Sustained Use of Benzodiazepines and Escalation to High Doses in a Canadian Population","volume":"67","author":"S Alessi-Severini","year":"2016","journal-title":"Psychiatr Serv"},{"key":"pone.0221438.ref009","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/M18-1757","article-title":"Elements of a Comprehensive Public Health Response to the Opioid Crisis","volume":"169","author":"M Levine","year":"2018","journal-title":"Ann Intern Med"},{"key":"pone.0221438.ref010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1753-6405.12030","article-title":"Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia","volume":"37","author":"SA Hollingworth","year":"2013","journal-title":"Aust N Z J Public Health"},{"key":"pone.0221438.ref011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/187447370802150928185302","article-title":"How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature","volume":"8","author":"S Mazumdar","year":"2015","journal-title":"Curr Drug Abuse Rev"},{"key":"pone.0221438.ref012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-018-0219-0","article-title":"Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation","volume":"19","author":"MM Islam","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"pone.0221438.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040116","article-title":"Variation in Prescription Opioid Dispensing across Neighborhoods of Diverse Socioeconomic Disadvantages in Victoria, Australia","volume":"11","author":"MM Islam","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"pone.0221438.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8030293","article-title":"Who Are Dispensed the Bulk Amount of Prescription Opioids?","volume":"8","author":"MM Islam","year":"2019","journal-title":"J Clin Med"},{"journal-title":"Australian Statistics on Medicines","year":"2014","author":"Australian Government Department of Health","key":"pone.0221438.ref015"},{"journal-title":"The Australian National Audit OfficeThe Auditor-General Audit Report No.39 2009\u201310","article-title":"Medicare Australia\u2019s Administration of the Pharmaceutical Benefits Scheme","year":"2010","key":"pone.0221438.ref016"},{"key":"pone.0221438.ref017","unstructured":"Department of Infrastructure and Regional Development (DIRD) (2015) Local government national report, 2013\u201314. Canberra, Australia: DIRD. Available at http:\/\/regional.gov.au\/local\/publications\/reports\/2013_2014\/INFRA2466_LGNR_2013-14.pdf."},{"key":"pone.0221438.ref018","article-title":"Guidelines for ATC Classification and DDD Assignment","author":"World Health Organization","year":"2017","journal-title":"Oslo: WHO Collaborating Centre for Drug Statistics Methodology"},{"volume-title":"meglm\u2014Multilevel mixed-effects generalized linear mode. Stata Statistical Software: Release 14","year":"2013","author":"StataCorp","key":"pone.0221438.ref019"},{"key":"pone.0221438.ref020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use- United States, 2006\u20132015","volume":"66","author":"A Shah","year":"2017","journal-title":"Morbidity and Mortal Weekly Report 2017"},{"key":"pone.0221438.ref021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid Overdose Deaths and Florida's Crackdown on Pill Mills","volume":"106","author":"A Kennedy-Hendricks","year":"2016","journal-title":"Am J Public Health"},{"key":"pone.0221438.ref022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","article-title":"Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005\u20132011","volume":"33","author":"B Fischer","year":"2014","journal-title":"Drug Alcohol Rev"},{"key":"pone.0221438.ref023","doi-asserted-by":"crossref","first-page":"k3207","DOI":"10.1136\/bmj.k3207","article-title":"Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada","volume":"362","author":"T Gomes","year":"2018","journal-title":"BMJ"},{"key":"pone.0221438.ref024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5694\/mja2.12026","article-title":"Concomitant prescribing of opioids and benzodiazepines in Australia, 2012\u20132017","volume":"210","author":"GE Caughey","year":"2019","journal-title":"Med J Aust"},{"key":"pone.0221438.ref025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"KE Vowles","year":"2015","journal-title":"Pain"},{"key":"pone.0221438.ref026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/dar.12893","article-title":"Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates","volume":"38","author":"GCK Chan","year":"2019","journal-title":"Drug Alcohol Rev"},{"key":"pone.0221438.ref027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1465-3362.2011.00326.x","article-title":"Pharmacuetical drugs: The delicate balance between reducing pain and reducing harm","volume":"30","author":"S Nielsen","year":"2011","journal-title":"Drug and Alcohol Review"},{"key":"pone.0221438.ref028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10826084.2017.1305415","article-title":"Prescription Opioid Misuse and Public Health Approach in Australia","volume":"53","author":"T Kovitwanichkanont","year":"2018","journal-title":"Subst Use Misuse"},{"key":"pone.0221438.ref029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5694\/mja2.12047","article-title":"Regulatory and other responses to the pharmaceutical opioid problem","volume":"210","author":"G Campbell","year":"2019","journal-title":"Med J Aust"},{"key":"pone.0221438.ref030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2018.03.036","article-title":"Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing","volume":"188","author":"EL Winstanley","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"pone.0221438.ref031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpain.2017.10.001","article-title":"Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers","volume":"19","author":"RA Deyo","year":"2018","journal-title":"J Pain"},{"key":"pone.0221438.ref032","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1162\/ajhe_a_00113","article-title":"Addressing the Opioid Epidemic: Is There a Role for Physician Education?","volume":"4","author":"M Schnell","year":"2018","journal-title":"Am J Health Econ"},{"key":"pone.0221438.ref033","doi-asserted-by":"crossref","first-page":"e1002625","DOI":"10.1371\/journal.pmed.1002625","article-title":"Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada","volume":"15","author":"A Russolillo","year":"2018","journal-title":"PLoS Med"},{"key":"pone.0221438.ref034","doi-asserted-by":"crossref","first-page":"e1002626","DOI":"10.1371\/journal.pmed.1002626","article-title":"Reducing the opioid overdose death toll in North America","volume":"15","author":"WD Hall","year":"2018","journal-title":"PLoS Med"},{"key":"pone.0221438.ref035","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.2016.15029","article-title":"As Opioid Epidemic Rages, Complementary Health Approaches to Pain Gain Traction","volume":"316","author":"J Abbasi","year":"2016","journal-title":"JAMA"},{"key":"pone.0221438.ref036","unstructured":"Therapeutic Goods Administration of Australian Government Department of Health (2018) Prescription strong (Schedule 8) opioid use and misuse in Australia\u2013options for a regulatory response. Consultation paper. Canberra."},{"key":"pone.0221438.ref037","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pds.3553","article-title":"Reductions in prescription opioid diversion following recent legislative interventions in Florida","volume":"23","author":"HL Surratt","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0221438.ref038","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jamainternmed.2016.2992","article-title":"Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use","volume":"176","author":"AL Schaffer","year":"2016","journal-title":"JAMA Intern Med"},{"key":"pone.0221438.ref039","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid Crisis: No Easy Fix to Its Social and Economic Determinants","volume":"108","author":"N Dasgupta","year":"2018","journal-title":"Am J Public Health"},{"key":"pone.0221438.ref040","doi-asserted-by":"crossref","first-page":"e0160217","DOI":"10.1371\/journal.pone.0160217","article-title":"Leveraging the Social Determinants of Health: What Works?","volume":"11","author":"LA Taylor","year":"2016","journal-title":"PLoS One"},{"key":"pone.0221438.ref041","unstructured":"Australian Institute of Health and Welfare (2017) Non-medical use of pharmaceuticals: trends, harms and treatment, 2006\u201307 to 2015\u201316. Drug treatment series no.30. Cat. no. HSE 195. Canberra:."},{"volume-title":"Tasmanian Drug Trends 2011. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 77. Sydney","year":"2012","author":"Graaff Bd","key":"pone.0221438.ref042"},{"key":"pone.0221438.ref043","article-title":"Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia","author":"L Degenhardt","year":"2013","journal-title":"Drug Alcohol Rev"},{"journal-title":"Pharmaceutical Services Branch data","year":"2017","author":"Department of Health and Human Services Tasmania","key":"pone.0221438.ref044"},{"key":"pone.0221438.ref045","article-title":"Challenges faced with opioid prescriptions in the community setting\u2014Australian pharmacists' perspectives","author":"CJ Makdessi","year":"2019","journal-title":"Res Social Adm Pharm"},{"journal-title":"Real-time Monitoring Ahead","year":"2019","author":"Pain Australia","key":"pone.0221438.ref046"},{"key":"pone.0221438.ref047","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5694\/mja12.10785","article-title":"Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential","volume":"198","author":"FL Shand","year":"2013","journal-title":"Med J Aust"},{"key":"pone.0221438.ref048","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5694\/mja15.00929","article-title":"Prescription drug monitoring in Australia: capacity and coverage issues","volume":"204","author":"RP Ogeil","year":"2016","journal-title":"Med J Aust"},{"key":"pone.0221438.ref049","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpain.2017.08.011","article-title":"Previous Mental Disorders and Subsequent Onset of Chronic Back or Neck Pain: Findings From 19 Countries","volume":"19","author":"MC Viana","year":"2018","journal-title":"J Pain"},{"key":"pone.0221438.ref050","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.3399\/bjgp17X691865","article-title":"Long-term benzodiazepine and Z-drugs use in England: a survey of general practice","volume":"67","author":"J Davies","year":"2017","journal-title":"Br J Gen Pract"},{"volume-title":"Australian Drug Trends 2018. Key findings from the National Illicit Drug Reporting System (IDRS) Interviews","year":"2018","author":"A Peacock","key":"pone.0221438.ref051"},{"key":"pone.0221438.ref052","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1526-4637.2010.00870.x","article-title":"Benzodiazepines predict use of opioids\u2014a follow-up study of 17,074 men and women","volume":"11","author":"S Skurtveit","year":"2010","journal-title":"Pain Med"},{"key":"pone.0221438.ref053","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/pds.4329","article-title":"To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?","volume":"27","author":"N Gisev","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0221438.ref054","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.1833","article-title":"Trends in long-term opioid therapy for chronic non-cancer pain","volume":"18","author":"D Boudreau","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0221438.ref055","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jama.2013.278344","article-title":"Chronic use of opioid medications before and after bariatric surgery","volume":"310","author":"MA Raebel","year":"2013","journal-title":"JAMA"},{"key":"pone.0221438.ref056","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s11606-017-4283-8","article-title":"Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010\u20132016","volume":"33","author":"K Hadlandsmyth","year":"2018","journal-title":"J Gen Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:04:20Z","timestamp":1588968260000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221438"}},"subtitle":[],"editor":[{"given":"Vijayaprakash","family":"Suppiah","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221438","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,8,19]]}}}